Medical School |
Imperial College School of Medicine, University of London, London, United Kingdom |
|
1998 |
MBBS (Hons) |
Residency |
Cleveland Clinic Foundation |
|
2000 |
Internship |
Residency |
University Hospitals/ Case Western Reserve University School of Medicine |
|
2003 |
Residency |
Fellowship |
Emory University School of Medicine |
|
2004 |
Fellowship |
Fellowship |
Cleveland Clinic Foundation Lerner Research Institute |
|
2006 |
Fellowship (research) |
|
Educational Commission for Foreign Medical Graduates |
1999 |
American Board of Psychiatry and Neurology |
2004 |
American Board of Electrodiagnostic Medicine |
2005 |
American Board of Psychiatry and Neurology- Clinical Neurophysiology |
2005 |
American Board of Psychaitry and Neurology- Neuromuscular Medicine |
2008 |
|
Appointment Type |
Department |
Division |
Rank |
Primary |
Neurology Chair Office |
Neurology Chair Office |
Professor |
Secondary |
Neurobiology |
Neurobiology |
Professor |
Center |
|
|
Professor |
Center |
Center for AIDS Research |
Center for AIDS Research |
Professor |
Center |
Ctr for Clinical & Translational Sci |
Ctr for Clinical & Translational Sci |
Professor |
Center |
Evelyn F. McKnight Brain Institute |
Evelyn F. McKnight Brain Institute |
Professor |
|
Organization Name |
Position Held |
Org Link |
American Academy of Neurology |
Member |
|
American Association for the Advancement of Science |
Member |
|
American Association of Neuromuscular & Electrodiagnostic Medicine |
Fellow |
|
American Neurological Association |
Fellow |
|
International AIDS Society |
Member |
|
New York Academy of Sciences |
Member |
|
Peripheral Nerve Society |
Member |
|
Society for Neuroscience |
Member |
|
|
Publication |
PUBMEDID |
Ubogu EE. Chemokine-dependent signaling pathways in the peripheral nervous system. Methods in Molecular Biology 2013; 1013:17-30 |
23625490 |
Zafar S, Goodman JC, Ubogu EE. A male with small vessel vasculitis presenting with brachial diplegia, multiple cranial mononeuropathies and severe orthostatic hypotension in diabetes mellitus: a case report. Journal of Medical Case Reports 2013: 7:229 |
24083508 |
Hannawi Y, Goldsmith CE, Kass JD, Olar A, Ubogu EE, Kalkonde Y. Chronic progressive axonal polyradiculoneuropathy associated with anti-CV2/CRMP5 antibodies. Journal of Clinical Neuromuscular Disease 2013;15:13-18 |
23965404 |
Lakshmana Reddy C, Yosef N, Ubogu EE. VEGF-A165 potently induces human blood-nerve barrier endothelial cell proliferation, angiogenesis and wound healing in vitro. Cellular and Molecular Neurobiology 2013; 33:789-801 |
23712256 |
Ubogu EE. The molecular and biophysical characterization of the human blood-nerve barrier: Current concepts. Journal of Vascular Research 2013; 50:289-303 |
23839247 |
Chiang S, Ubogu EE. The role of chemokines in Guillain-Barré syndrome. Muscle and Nerve 2013;48:320-330 |
23447114 |
Yosef N, Ubogu EE. An immortalized human blood-nerve barrier endothelial cell line for in vitro permeability studies. Cellular and Molecular Neurobiology 2013; 33:175-186 |
23104242 |
Ubogu EE. Translational strategies in peripheral neuroinflammation and neurovascular repair. Translational Neuroscience 2012; 3: 373-383 |
23638307 |
Salisbury EA, Lazard ZW, Ubogu EE, Davis AR, Olmstead-Davis EA. Transient brown adipocyte-like cells derive from peripheral nerve progenitors in response to bone morphogenetic protein 2. Stem Cells Translational Medicine 2012; 1: 874-885 |
23283549 |
Yosef N, Ubogu EE. Alpha M beta 2-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro. Journal of Cellular Physiology 2012; 227:3857-3875 |
22552879 |
Yosef N, Ubogu EE. GDNF restores human blood-nerve barrier function via RET tyrosine kinase-mediated cytoskeletal reorganization. Microvascular Research 2012; 83:298-310 |
22326552 |
Ubogu EE, Yosef N, Xia RH, Sheikh KA. Behavioral, electrophysiological and histopathological characterization of a severe murine chronic demyelinating polyneuritis model. Journal of the Peripheral Nervous System 2012; 17: 53-61 |
22462666 |
Ubogu EE. Chemokine receptors as specific anti-inflammatory targets in peripheral nerves. Endocrine, Metabolic and Immune Disorders-Drug Targets 2011;11:141-153 |
21476965 |
Xia RH, Yosef N, Ubogu EE. Selective expression and cellular localization of pro-inflammatory chemokine ligand/receptor pairs in the sciatic nerves of a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome. Neuropathology and Applied Neurobiology 2010; 36:388-398 |
2050055 |
Xia RH, Yosef N, Ubogu EE. Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice. Technical aspects and normative data. Muscle and Nerve 2010;41:850-856 |
20151466 |
Xia RH, Yosef N, Ubogu EE. Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome. Journal of Neuroimmunology 2010; 219:54-63 |
20034679 |
Yosef N, Xia RH, Ubogu EE. Development and characterization of a novel human in vitro blood-nerve barrier model using primary endoneurial endothelial cells. Journal of Neuropathology and Experimental Neurology 2010; 69:82-97 |
20010300 |
|
|